Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
MORTONS RESTAURANT GROUP INC (MRT)
|
Add to portfolio |
|
|
|
| Price: |
$11.03
| | Metrics |
| OS: |
16.9
|
M
| |
14
|
% ROE
|
| Market cap: |
$186
|
M
| |
14
|
% ROIC
|
|
Net debt:
|
$68.2
|
M
| |
|
|
|
EV:
|
$255
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
$12.8
|
M
| |
19.8
|
x EV/EBIT
|
| EPS |
$0.50
| |
22.0
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
| Date Filed | Type | Description |
| 04/29/2019 |
GN
| STI, MRT, and TCF SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers |
| 04/29/2019 |
GN
| STI, MRT, TCF Merger Class Action Alert: Halper Sadeh LLP Reminds Investors of Shareholder Lawsuits Filed Against These Companies – STI, MRT, TCF |
| 04/15/2019 |
GN
| MedEquities (MRT) Merger Class Action Lawsuit: Halper Sadeh LLP Announces Filing of Shareholder Class Action Lawsuit Against MedEquities Realty Trust, In...
|
| 03/04/2019 |
GN
| MERGER ALERT –MRT, NUBK, and ELLI: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies |
| 02/22/2019 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of MedEquities, TCF Financial, and Kinderhook on Behalf of...
|
| 02/20/2019 |
GN
| MEDEQUITIES REALTY TRUST, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger |
| 02/20/2019 |
GN
| INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of MedEquities Realty Trust, Inc. to Omega Healthc...
|
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jan-02-11 | Jan-03-10 | Jan-04-09 | Dec-30-07 | Dec-31-06 | Jan-01-06 | Jan-02-05 | Jan-04-04 |
| Revenues | 296.1 | 281.1 | 329.4 | 325.8 | 322.0 | 300.7 | 276.3 | 258.7 |
| Revenue growth | 5.3% | -14.7% | 1.1% | 1.2% | 7.1% | 8.8% | 6.8% | |
| Cost of goods sold | 161.3 | 156.1 | 164.9 | 150.5 | 151.1 | 141.0 | 127.0 | 124.1 |
| Gross profit | 134.8 | 125.0 | 164.5 | 175.3 | 170.9 | 159.7 | 149.3 | 134.6 |
| Gross margin | 45.5% | 44.5% | 49.9% | 53.8% | 53.1% | 53.1% | 54.0% | 52.0% |
| Sales and marketing | 6.3 | 6.7 | 7.0 | 7.0 | 6.1 | 5.5 | 8.5 | 5.9 |
| General and administrative | 16.7 | 15.9 | 26.5 | 27.2 | 23.0 | 22.6 | 18.9 | 16.7 |
| EBIT | 9.3 | -7.5 | 6.7 | 18.6 | 14.3 | 12.6 | 18.4 | 16.7 |
| EBIT margin | 3.2% | -2.7% | 2.0% | 5.7% | 4.4% | 4.2% | 6.7% | 6.4% |
| Pre-tax income | 5.2 | -41.4 | -70.6 | 28.7 | -18.7 | -4.3 | 4.1 | 5.5 |
| Income taxes | 1.2 | 36.4 | -8.8 | 1.2 | -5.1 | -0.1 | 4.9 | 1.2 |
| Tax rate | 22.4% | | 12.4% | 4.0% | 27.1% | 2.2% | 117.9% | 22.4% |
| Earnings from continuing ops | 8.7 | -155.2 | -123.7 | 27.5 | -13.6 | -4.2 | -0.7 | 4.2 |
| Earnings from discontinued ops | -4.2 | -4.3 | -11.7 | -1.5 | | | | |
| Net income | 2.0 | -79.9 | -67.7 | 13.0 | -13.6 | -4.2 | -0.7 | 4.2 |
| Net margin | 0.7% | -28.4% | -20.6% | 4.0% | -4.2% | -1.4% | -0.3% | 1.6% |
| |
| Diluted EPS | $0.50 | ($9.77) | ($7.69) | $1.62 | ($0.84) | ($0.42) | ($0.07) | $0.42 |
| Shares outstanding (diluted) | 17.4 | 15.9 | 16.1 | 17.0 | 16.1 | 10.1 | 10.1 | 10.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|